Malignant hypertension remains one of the life-threatening complications of
blood pressure elevation. It is a clinico-pathological syndrome of severe
blood pressure elevation combined with malignant vascular injury. This is a
characteristic form of vascular damage,,vith two elements: fibrinoid necro
sis and endarteritis proliferans. Although the morphology of these has been
well described, the molecular events are not fully understood. This review
summarizes the evidence from transgenic animals for a role for the activat
ion of a local paracrine renin-angiotensin system in the pathogenesis of ma
lignant vascular injury. These animal models provide pathological, pharmaco
logical, and genetic evidence supporting the hypothesis that intra-renal ge
neration of angiotensin 2 and exposure of the microcirculation to elevated
blood pressure cooperate in causing tissue damage in malignant hypertension
. Copyright (C) 2000 John Wiley & Sons, Ltd.